Mrs. Averill Burger, FNP-BC Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 26 Red Oak Dr, Culloden, WV 25510 Phone: 304-690-5110 |
News Archive
Curis, Inc. , a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the 8th Annual BIO Investor Forum at 4:30 p.m. PDT (7:30 p.m. EDT) on October 28, 2009, at the Palace Hotel in San Francisco, California.
Patients treated at UMDNJ-University Hospital for heart failure receive some of the best care in the nation, according to newly released rankings. The data, from the University HealthSystem Consortium (UHC), place the hospital among the top five academic medical centers in the nation for treating heart failure patients with recommended care. This care was measured in the areas of discharge instructions, appropriate prescriptions of heart failure medications at discharge, evaluation of left heart function, and adult smoking cessation advice/counseling.
Researchers at Oregon Health & Science University have discovered a new mechanism within human cells that constantly protects us against disease. P. Michael Conn, Ph.D., a researcher at the OHSU Oregon National Primate Research Center directed the work. The findings are reported in the Feb. 15 issue of the journal Proceedings of the National Academy of Sciences.
As President Barack Obama is pilloried for the rocky rollout of the law, the White House struggles with how to refocus the public's attention, since some of the strongest arguments for the law are longer-term benefits that are harder to comprehend.
Ventrus Biosciences Inc., a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced that it closed its previously announced public offering of 2,900,000 shares of common stock.
› Verified 2 days ago